Decentralized Manufacturing for Cell Therapy

Advance Scalability, Accessibility and Affordability of Autologous Cell Therapies

As the cell therapy space bears witness to an increasing number of autologous therapies gaining regulatory approval, the essential role of the manufacturing ecosystem has never been clearer. It is business critical for cell therapy drug developers to have a robust strategy for scale up whilst overcoming the labour and cost intensive nature of batch manufacturing to reduce the cost of goods.

Time: 9:00 am – 3:45 pm

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices: USD 2599.00 – USD 5297.00

Speakers: Richard McFarland, Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute, Scott Berger, Principal Consultant, Advanced Cell and Gene Therapy, Amish Patel, Vice President Technical Operations, Calidi Biotherapeutics, and more.